SU‐GG‐T‐43

Physics Commissioning in Xoft Axxent® Electronic Brachytherapy (eBx) for the Primary Treatment of Non‐Melanoma Skin Cancer

Yi Rong, B. Paliwal, J. Welsh

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Purpose: The Xoft Axxent® X‐ray source has been used for treating non‐melanoma skin cancer since the surface applicators became clinically available in the summer of 2009. We report a comprehensive quality assurance (QA) procedure for the commissioning of the Electronic Brachytherapy (eBx) system with the Xoft surface applicators. Materials and methods: The Xoft miniature tube (model S700) generates 50kVp low‐energy x‐rays. The new surface applicators used with this device have four available sizes of 10mm, 20mm, 35mm, and 50mm in diameter. Our tests include dose‐rate measurement, air‐gap factor, output stability, energy verification, beam flatness and symmetry, timer linearity and treatment planning with patientspecific cutout factors. TG‐61 in‐air method was used as a guideline for acquiring nominal dose rate output at the skin surface. Soft x‐ray parallel plate chamber (PTW T34013) and electrometer was used for the output commissioning. Gafchromic(R) EBT films were used for testing the properties of the treatment fields with the skin applicators. Solid water slabs were used to verify the source energy and measure cutout factors. Results: The average nominal dose‐rate output at the skin surface for the 35mm applicator is 1.35 Gy/min with ±5% variation for fifteen sources. For the same source, the output variation is within 2%. The effective SSD was also calculated based on the air‐gap measurements for four applicator sizes. The field flatness and symmetry are well within 5%. Treatment duration is calculated based on the nominal dose‐rate, the prescription fraction size, the depth dose percentage, and the cutout factor. Conclusion: Together with TG‐61, our methodology provides a comprehensive commissioning procedure for medical physicists in using the Xoft eBx system and skin applicators for the treatment of non‐melanoma skin cancer.

Original languageEnglish (US)
Number of pages1
JournalMedical Physics
Volume37
Issue number6
DOIs
StatePublished - Jan 1 2010
Externally publishedYes

Fingerprint

Physics
Brachytherapy
Skin Neoplasms
Skin
X-Rays
Silver Sulfadiazine
Therapeutics
Prescriptions
Guidelines
Equipment and Supplies
Water

ASJC Scopus subject areas

  • Biophysics
  • Radiology Nuclear Medicine and imaging

Cite this

SU‐GG‐T‐43 : Physics Commissioning in Xoft Axxent® Electronic Brachytherapy (eBx) for the Primary Treatment of Non‐Melanoma Skin Cancer. / Rong, Yi; Paliwal, B.; Welsh, J.

In: Medical Physics, Vol. 37, No. 6, 01.01.2010.

Research output: Contribution to journalArticle

@article{f471f84824264f57abf26ba2e3c262eb,
title = "SU‐GG‐T‐43: Physics Commissioning in Xoft Axxent{\circledR} Electronic Brachytherapy (eBx) for the Primary Treatment of Non‐Melanoma Skin Cancer",
abstract = "Purpose: The Xoft Axxent{\circledR} X‐ray source has been used for treating non‐melanoma skin cancer since the surface applicators became clinically available in the summer of 2009. We report a comprehensive quality assurance (QA) procedure for the commissioning of the Electronic Brachytherapy (eBx) system with the Xoft surface applicators. Materials and methods: The Xoft miniature tube (model S700) generates 50kVp low‐energy x‐rays. The new surface applicators used with this device have four available sizes of 10mm, 20mm, 35mm, and 50mm in diameter. Our tests include dose‐rate measurement, air‐gap factor, output stability, energy verification, beam flatness and symmetry, timer linearity and treatment planning with patientspecific cutout factors. TG‐61 in‐air method was used as a guideline for acquiring nominal dose rate output at the skin surface. Soft x‐ray parallel plate chamber (PTW T34013) and electrometer was used for the output commissioning. Gafchromic(R) EBT films were used for testing the properties of the treatment fields with the skin applicators. Solid water slabs were used to verify the source energy and measure cutout factors. Results: The average nominal dose‐rate output at the skin surface for the 35mm applicator is 1.35 Gy/min with ±5{\%} variation for fifteen sources. For the same source, the output variation is within 2{\%}. The effective SSD was also calculated based on the air‐gap measurements for four applicator sizes. The field flatness and symmetry are well within 5{\%}. Treatment duration is calculated based on the nominal dose‐rate, the prescription fraction size, the depth dose percentage, and the cutout factor. Conclusion: Together with TG‐61, our methodology provides a comprehensive commissioning procedure for medical physicists in using the Xoft eBx system and skin applicators for the treatment of non‐melanoma skin cancer.",
author = "Yi Rong and B. Paliwal and J. Welsh",
year = "2010",
month = "1",
day = "1",
doi = "10.1118/1.3468429",
language = "English (US)",
volume = "37",
journal = "Medical Physics",
issn = "0094-2405",
publisher = "AAPM - American Association of Physicists in Medicine",
number = "6",

}

TY - JOUR

T1 - SU‐GG‐T‐43

T2 - Physics Commissioning in Xoft Axxent® Electronic Brachytherapy (eBx) for the Primary Treatment of Non‐Melanoma Skin Cancer

AU - Rong, Yi

AU - Paliwal, B.

AU - Welsh, J.

PY - 2010/1/1

Y1 - 2010/1/1

N2 - Purpose: The Xoft Axxent® X‐ray source has been used for treating non‐melanoma skin cancer since the surface applicators became clinically available in the summer of 2009. We report a comprehensive quality assurance (QA) procedure for the commissioning of the Electronic Brachytherapy (eBx) system with the Xoft surface applicators. Materials and methods: The Xoft miniature tube (model S700) generates 50kVp low‐energy x‐rays. The new surface applicators used with this device have four available sizes of 10mm, 20mm, 35mm, and 50mm in diameter. Our tests include dose‐rate measurement, air‐gap factor, output stability, energy verification, beam flatness and symmetry, timer linearity and treatment planning with patientspecific cutout factors. TG‐61 in‐air method was used as a guideline for acquiring nominal dose rate output at the skin surface. Soft x‐ray parallel plate chamber (PTW T34013) and electrometer was used for the output commissioning. Gafchromic(R) EBT films were used for testing the properties of the treatment fields with the skin applicators. Solid water slabs were used to verify the source energy and measure cutout factors. Results: The average nominal dose‐rate output at the skin surface for the 35mm applicator is 1.35 Gy/min with ±5% variation for fifteen sources. For the same source, the output variation is within 2%. The effective SSD was also calculated based on the air‐gap measurements for four applicator sizes. The field flatness and symmetry are well within 5%. Treatment duration is calculated based on the nominal dose‐rate, the prescription fraction size, the depth dose percentage, and the cutout factor. Conclusion: Together with TG‐61, our methodology provides a comprehensive commissioning procedure for medical physicists in using the Xoft eBx system and skin applicators for the treatment of non‐melanoma skin cancer.

AB - Purpose: The Xoft Axxent® X‐ray source has been used for treating non‐melanoma skin cancer since the surface applicators became clinically available in the summer of 2009. We report a comprehensive quality assurance (QA) procedure for the commissioning of the Electronic Brachytherapy (eBx) system with the Xoft surface applicators. Materials and methods: The Xoft miniature tube (model S700) generates 50kVp low‐energy x‐rays. The new surface applicators used with this device have four available sizes of 10mm, 20mm, 35mm, and 50mm in diameter. Our tests include dose‐rate measurement, air‐gap factor, output stability, energy verification, beam flatness and symmetry, timer linearity and treatment planning with patientspecific cutout factors. TG‐61 in‐air method was used as a guideline for acquiring nominal dose rate output at the skin surface. Soft x‐ray parallel plate chamber (PTW T34013) and electrometer was used for the output commissioning. Gafchromic(R) EBT films were used for testing the properties of the treatment fields with the skin applicators. Solid water slabs were used to verify the source energy and measure cutout factors. Results: The average nominal dose‐rate output at the skin surface for the 35mm applicator is 1.35 Gy/min with ±5% variation for fifteen sources. For the same source, the output variation is within 2%. The effective SSD was also calculated based on the air‐gap measurements for four applicator sizes. The field flatness and symmetry are well within 5%. Treatment duration is calculated based on the nominal dose‐rate, the prescription fraction size, the depth dose percentage, and the cutout factor. Conclusion: Together with TG‐61, our methodology provides a comprehensive commissioning procedure for medical physicists in using the Xoft eBx system and skin applicators for the treatment of non‐melanoma skin cancer.

UR - http://www.scopus.com/inward/record.url?scp=85024812503&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85024812503&partnerID=8YFLogxK

U2 - 10.1118/1.3468429

DO - 10.1118/1.3468429

M3 - Article

VL - 37

JO - Medical Physics

JF - Medical Physics

SN - 0094-2405

IS - 6

ER -